Cite
HARVARD Citation
Owonikoko, T. et al. (2016). Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer. Journal of translational medicine. 14 (1), pp. 1-14. [Online].